Recent Company News

• 01:20 AM ET Apr 30, 2025
  

  StreetAccount Metrics Recap - DSM-Firmenich Q1 Earnings (€94.58, 0.00)

• 01:11 AM ET Apr 30, 2025
  

  DSM-Firmenich reports Q1 revenue €3.27B vs consensus €3.28B (€94.58, 0.00)

• 07:54 AM ET Apr 28, 2025
  

  StreetAccount Consensus Metrics Preview - DSM-Firmenich Q1 Earnings (€93.60, +0.68)

• 04:10 AM ET Apr 07, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (411 total)

• 01:02 AM ET Apr 03, 2025
  

  dsm-firmenich increases its stake in Andre Pectin to 90.5%; financial details not disclosed (€91.00, 0.00)

• 02:08 PM ET Apr 02, 2025
  

  DSM-Firmenich's animal nutrition and health unit reportedly sees interest from private equity bidders -- Bloomberg (€91.00, 0.00)

• 01:02 AM ET Apr 01, 2025
  

  dsm-firmenich to commence already communicated share repurchase program (€91.36, 0.00)

• 05:29 AM ET Mar 25, 2025
  

  DSM-Firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day (€90.96, -0.66)

• 05:14 AM ET Mar 25, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (91 total)

• 01:06 AM ET Feb 28, 2025
  

  DSM-Firmenich publishes 2024 Integrated Annual Report (€101.50, 0.00)